1-5 of 5
Lela M. Lucy, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study

Hartmut Döhner, MD, John F Seymour, MBBS, FRACP, PhD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, FRCPC, Andre C Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M. Stone, MD, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 621.
https://doi.org/10.1182/blood.V124.21.621.621
Published: 2014
Journal Articles

Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (>30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial

John F Seymour, MBBS, FRACP, PhD, Hartmut Döhner, MD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, MD, Andre C. Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M Stone, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 10.
https://doi.org/10.1182/blood.V124.21.10.10
Published: 2014
Journal Articles

Identification of a DNA Methylation Predictive Signature of Overall Survival in Higher-Risk MDS Patients Treated with Azacitidine,

Tao Shi, PhD, Ludmila Danilova, PhD, Xiaolong Luo, PhD, Lela M. Lucy, MS, CL Beach, PharmD, Leslie Cope, PhD, James G. Herman, MD, Kyle J. MacBeth, PhD
Journal: Blood
Blood (2011) 118 (21): 3815.
https://doi.org/10.1182/blood.V118.21.3815.3815
Published: 2011
Journal Articles

Achievement of Red Blood Cell (RBC) Transfusion Independence with Azacitidine (AZA) Leads to Improved Survival In Patients with Higher-Risk Myelodysplasias Regardless of Baseline Transfusion Needs

John F Seymour, MD, FRACP, Valeria Santini, MD, Pierre Fenaux, MD, Aristoteles A.N. Giagounidis, MD, Guillermo F. Sanz, MD, PhD, Carlo Finelli, MD, Lela M. Lucy, MS, Jay Backstrom, MD, MPH, CL Beach, PharmD
Journal: Blood
Blood (2010) 116 (21): 1856.
https://doi.org/10.1182/blood.V116.21.1856.1856
Published: 2010
Journal Articles

Re-Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA-001 Study with Higher-Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Norbert Gattermann, MD, Guillermo F. Sanz, MD, PhD, Aristoteles Giagounidis, John F Seymour, MD, FRACP, Pierre Fenaux, MD, PhD, Valeria Santini, MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Petra Muus, MD, PhD, Fernando Ramos, MD, Lela M. Lucy, MS, CL Beach, PharmD, Lewis R. Silverman, MD
Journal: Blood
Blood (2010) 116 (21): 4031.
https://doi.org/10.1182/blood.V116.21.4031.4031
Published: 2010